Introduction . Hypoglycemic drugs affect the bone quality and the risk of fractures in patients with type 2 diabetes mellitus (T2DM). We aimed to investigate the effects of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and insulin on bone mineral density (BMD) in T2DM. Methods . In this si…